Summary
Mathis Pharma has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €557k and a net result of €72k. Equity is growing by ~15.7% per year across the filed fiscal years. Its solvency ranks better than 50% of 8663 sector peers (fiscal year 2025). The company has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Outside the general model
Holding: general score not applicable
The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.
Credit check for your own amount and term
Signals
1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-08-2026, 30 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
30 d late
2024
28 d late
2023
1 d early
2022
7 d early
2021
39 d early
2020
5 d early
2019
17 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€557k▲ 8.1%
2024 · €516k
2019: €235k
2020: €269k
2021: €313k
2022: €366k
2023: €414k
2024: €516k
2019 → 2025
Total assets
€1.06M▲ 0.1%
2024 · €1.05M
2019: €970k
2020: €964k
2021: €974k
2022: €978k
2023: €966k
2024: €1.05M
2019 → 2025
Net result
€72k▼ 44.4%
2024 · €130k
2019: €68k
2020: €34k
2021: €45k
2022: €54k
2023: €42k
2024: €130k
2019 → 2025
Working capital
€-137k▼ 3.9%
2024 · €-132k
2019: €-189k
2020: €-202k
2021: €-199k
2022: €-188k
2023: €-182k
2024: €-132k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€313k-€366k▲ 17.0%€414k▲ 12.9%€516k▲ 24.6%€557k▲ 8.1%
Operating result€79k-€91k▲ 15.1%€75k▼ 17.4%€114k▲ 52.3%€90k▼ 21.0%
Net result€45k-€54k▲ 19.1%€42k▼ 22.3%€130k▲ 210%€72k▼ 44.4%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 21% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.06M
Fixed assets
€907k ▼ 0.3%
Current assets
€148k ▲ 2.5%
Equity and liabilities €1.06M
Equity
€557k ▲ 8.1%
Provisions
€20k =
Debt
€478k ▼ 7.8%
Debt's share of the balance-sheet total falls from 49.2% to 45.3%. Equity is higher and debt is lower.
Key figures and ratios
ROE
13.0%▼
2024 · 25.3%
ROA
6.9%▼
2024 · 12.4%
Debt ≤ 1 year
€285k▲
2024 · €276k
Debt > 1 year
€177k▼
2024 · €219k
Income taxes
€23k▼
2024 · €33k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 50 lines
Balance sheet
Code20242025
Assets
Total assets20/58€1.05M€1.06M▲
Fixed assets21/28€910k€907k▼
Tangible fixed assets22/27€3k-
Furniture and vehicles24€3k-
Financial fixed assets28€907k€907k=
Current assets29/58€145k€148k▲
Amounts receivable within one year40/41€31k€39k▲
Trade receivables40-€15k
Other amounts receivable41€31k€24k▼
Current investments50/53€70k€69k▼
Cash at bank and in hand54/58€43k€39k▼
Deferred charges and accrued income490/1€925€1k▲
Equity and liabilities
Total equity and liabilities10/49€1.05M€1.06M▲
Equity10/15€516k€557k▲
Contributions10/11€19k€19k=
Reserves13€497k€539k▲
Distributable reserves133€497k€539k▲
Provisions and deferred taxes16€20k€20k=
Provisions for liabilities and charges160/5€20k€20k=
Pensions and similar obligations160€20k€20k=
Amounts payable17/49€519k€478k▼
Amounts payable after more than one year17€219k€177k▼
Financial debts170/4€219k€177k▼
Amounts payable within one year42/48€276k€285k▲
Current portion of amounts payable after more than one year42€41k€42k▲
Trade debts44€9k€9k▲
Suppliers440/4€9k€9k▲
Taxes, remuneration and social security45€25k€24k▼
Taxes450/3€22k€22k▼
Remuneration and social security454/9€3k€3k▲
Other amounts payable47/48€202k€210k▲
Accrued charges and deferred income492/3€23k€16k▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€12k€3k▼
Other operating charges640/8€3k€2k▼
Gross operating margin9900€128k€94k▼
Operating profit (loss)9901€114k€90k▼
Financial income75/76B€77k€23k▼
Recurring financial income75€77k€23k▼
Financial charges65/66B€28k€17k▼
Recurring financial charges65€28k€17k▼
Profit (loss) for the period before taxes9903€163k€96k▼
Income taxes67/77€33k€23k▼
Profit (loss) for the period9904€130k€72k▼
Profit (loss) for the period to be appropriated9905€130k€72k▼
Appropriation of the result
Profit (loss) to be appropriated9906€130k€72k▼
Transfer from equity791/2€28k€31k▲
Transfer to equity691/2€130k€72k▼
To other reserves6921€130k€72k▼
Profit to be distributed694/7€28k€31k▲
Return on contributions (dividend)694€28k€31k▲
The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 30 days late
2025
28-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 28 days late
2024
31-12
Financial
Highest result since 2019net €130k ▲210%
Operating result €114k, net result €130k, both a record.
31-12
Financial
Equity above €500kEq €516k ▲24.6%
6 profitable years in a row build equity to €516k.
30-01
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
24-01
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2021
23-12
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
26-01
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
30-06
Financial
Weakest financial yearnet €34k ▼49.7%
Net result drops to €34k, the lowest in the series; recovery starts the following year.
14-01
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
10-01
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
15-01
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2016
29-11
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brugge · 1 establishment unit since 2006
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Astridlaan 374a8310 BruggeGround area
192 m²
Building footprint
99 m²
Volume, LiDAR
739 m³
Parcel 31434C0262/00H000, Flanders · tallest building 10.4 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Deschilder Isabelle
since 20062.250.225.103
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 31434C0262/00H000 | Flanders | 191 m² | 1 · 99 m² | 10.4 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
GVDB
BE 0790.543.367
Chaudfontaine · Eq €557,269
PhaRa
BE 0477.045.208
Antwerpen · Eq €557,175
Lorraine ECA
BE 0838.138.101
Ukkel · Eq €557,305
Mailing SOLUTIONS
BE 0473.841.634
Wavre · Eq €557,367
Vranken-Fossépré
BE 0534.594.813
Antwerpen · Eq €557,423
Of 82,562 companies in sector 70200 we hold annual accounts for 52,574. 33,765 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded19-07-2006
Fiscal year end31-12
Activities, NACEBEL 2025
70200Business and other management consultancy
47730Retail sale of pharmaceutical products
64210Activities of holding companies
Sources
Crossroads Bank for EnterprisesNational Bank · 19 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.